| Application no. and date | 14837210.5 (espacenet) (Federated) (European Patent Register), 20140822 | | Patent/reg. no. and date | DK/EP 3037424, 20171108 | | Publication date | 20160629 | | Priority no. and date | JP 2013172746, 20130822 | | EP pub. no. and date |
EP 3037424 20160629 | | Effective date | | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27 Kandanishiki-cho Chiyoda-ku
Tokyo 101-8444, JP | | Applicant ref. no. | P63083DK01 | | Inventor | NONOSHITA, Katsumasa, c/o TAIHO PHARMACEUTICAL CO. LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP,
UNO, Takao, c/o TAIHO PHARMACEUTICAL CO. LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP,
SHIMAMURA, Tadashi, c/o TAIHO PHARMACEUTICAL CO. LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 31/55 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07D 487/14 (2006.01) | | Title | NY QUINOLIN-SUBSTITUERET FORBINDELSE | | Int. application no. | JP2014071951 | | Int. publication no. | WO2015025936 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
